Effect of Indometacin on abortion

Evaluation of the effects of Indometacin suppository on decreasing of abortion in multi fetal pregnancy for fetal reduction

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190113042349N1

Enrollment

Registered

2019-03-09

Start date

2019-01-21

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion. miscarriage

Interventions

Intervention 1: Intervention group: Indomethacin suppository 50 mg, half an hour before fetus reduction via rectal, made in Toliddaroo Company. Intervention 2: Control group: without any intervention.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women in first trimester pregnancy No allergy to Indometacin Satisfaction to entry on study Multiple pregnancy

Exclusion criteria

Exclusion criteria: Allergy to Indometacin

Design outcomes

Primary

Measure	Time frame
The effect of abortion in reduction of embryos of multiple pregnancies operation. Timepoint: 21 day after intervention. Method of measurement: Research made questionnaire.;The effect on Pain. Timepoint: 21 day after intervention. Method of measurement: Research made questionnaire.	—

Secondary

Measure	Time frame
. Timepoint: . Method of measurement: .	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahedeh Kamali Taghavi

Tehran University of Medical Sciences

zahedeh_kamali@yahoo.com+98 21 8899 5767

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026